CNVS Form 4: CFO Disposes 119,168 Shares; 138K RSUs Vest Through 2028
Rhea-AI Filing Summary
Mark W. Lindsey, CFO of Cineverse Corp. (CNVS), reported changes in his beneficial ownership on Form 4. The filing shows a disposition of 119,168 shares of Class A common stock on 09/23/2025. It also reports outstanding equity awards: a Stock Appreciation Right exercisable at $11.95 covering 20,000 underlying shares expiring 11/14/2032, and multiple Restricted Stock Units (RSUs) totaling 138,366 RSUs across different grant schedules that vest between 2025 and 2028. Specific vesting schedules are included for each award.
Positive
- Detailed vesting schedules for RSUs and SARs are disclosed, showing alignment of executive compensation with multi‑year retention
- Stock appreciation rights and large RSU grants indicate continued incentive alignment with shareholders
Negative
- Disposition of 119,168 Class A shares on 09/23/2025 by the CFO is a material insider sale reported on Form 4
- Filing does not state whether the sale was under a prearranged trading plan, leaving rationale unclear
Insights
TL;DR: Insider reported a sizeable share disposition and holds significant time‑based equity awards that vest over 2025–2028.
The reported 119,168‑share disposition on 09/23/2025 is a clear, reportable sale by the CFO and is notable for size but the filing does not state the reason or proceeds. Offsetting long‑term holdings include a $11.95 strike SAR covering 20,000 shares and 138,366 RSUs that vest in tranches through 2028, indicating ongoing alignment with shareholder value through multi‑year vesting. Without company market cap or share count in the filing, the percentage impact on ownership cannot be determined from this document alone.
TL;DR: Transaction appears routine—an insider sale plus standard executive compensation vesting schedules.
The Form 4 documents a sale and standard equity compensation instruments: SARs with staged vesting and RSUs with scheduled vesting dates (notably 09/23 and 04/25 tranches). Such disclosures are customary and support retention incentives. The filing is complete in listing vesting dates and amounts but does not disclose whether the sale was pre‑arranged under a trading plan. From a governance perspective, documentation of vesting timelines is useful for assessing incentive structure but the filing alone does not indicate unusual governance risk.